Valuation: Active Biotech AB

Market Cap 92.53M 9.17M 8.33M 7.69M 6.95M 13.12M 861M 13.58M 36.66M 462M 34.39M 33.67M 1.46B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 92.53M 9.17M 8.33M 7.69M 6.95M 13.12M 861M 13.58M 36.66M 462M 34.39M 33.67M 1.46B EV / Sales 2026 *
-
EV / Sales 2027 * 1.58x
Free-Float
83.01%
Yield 2026 *
-
Yield 2027 * -
1 day-0.85%
1 week+1.74%
Current month-12.14%
1 month+11.96%
3 months-32.37%
6 months-46.66%
Current year-23.70%
1 week 3.39
Extreme 3.39
3.69
1 month 3.1
Extreme 3.1
4.18
Current year 3.1
Extreme 3.1
9.43
1 year 3.1
Extreme 3.1
9.5
3 years 3.1
Extreme 3.1
147.8
5 years 3.1
Extreme 3.1
152
10 years 3.1
Extreme 3.1
2,190
Manager TitleAgeSince
Chief Executive Officer 64 30/06/2017
Director of Finance/CFO 75 31/12/1999
Chief Tech/Sci/R&D Officer - 31/12/2021
Director TitleAgeSince
Director/Board Member 70 06/04/2011
Chairman 61 22/05/2019
Director/Board Member 76 22/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.85%+1.74%-53.26%-94.37% 9.17M
-1.29%-3.91%+51.98%+69.06% 65.56B
-0.09%+2.79%+12.54%+95.02% 60.41B
+0.63%+1.64%+23.11%+89.70% 55.76B
-1.26%-1.45%+12.43%+117.42% 46.98B
-0.15%-5.06%+20.00%+29.27% 43.63B
-3.15%-16.63%+146.30%+685.27% 36.09B
+0.23%+2.14%+14.85%+46.22% 36.7B
+2.35%-3.61%+80.65%+60.70% 32.9B
+1.42%+5.84%-36.40%+402.78% 26.96B
Average -0.22%-0.68%+27.22%+150.11% 40B
Weighted average by Cap. -0.27%-1.08%+35.57%+151.47%

Financials

2026 *2027 *
Net sales - 58.6M 5.81M 5.27M 4.87M 4.4M 8.31M 545M 8.6M 23.22M 293M 21.78M 21.32M 927M
Net income -33.2M -3.29M -2.99M -2.76M -2.49M -4.71M -309M -4.87M -13.15M -166M -12.34M -12.08M -525M 25.1M 2.49M 2.26M 2.09M 1.89M 3.56M 233M 3.68M 9.95M 125M 9.33M 9.13M 397M
Net Debt - -
Projected Income Statement - Annual - Active Biotech AB
Logo Active Biotech AB
Active Biotech AB (publ) is a Sweden-based Company, which develops pharmaceutical products within medical areas where the immune defense is important, including cancer and inflammatory diseases. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
Employees
5
Date Price Change Volume
16/11/26 SEK 3.510 -0.85% 4,234
13/11/26 SEK 3.540 +0.71% 23,922
12/11/26 SEK 3.515 -2.36% 36,167
11/11/26 SEK 3.600 +4.20% 85,584
10/11/26 SEK 3.455 +0.14% 30,272
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - Active Biotech AB
  1. Stock Market
  2. Stocks
  3. ACTI Stock